Le Lézard
Classified in: Health, Science and technology, Business
Subject: MAT

My CBD Potion Launches E-Commerce Website


TITUSVILLE, Fla., Sept. 14, 2019 /PRNewswire-PRWeb/ -- My CBD Potion is a hemp-derived CBD product made from an exclusive strain of hemp bred to contain more cannabidiol (CBD). The hemp used to make My CBD Potion is 100% organic, grown on 72 pristine acres of farmland in southern Oregon ? the best climate for growing hemp. (In other words, our hemp is happy ? and you will be, too!)

The hemp is gently hand-harvested before undergoing a CO2 extraction process that utilizes the whole hemp plant. Unlike other CBD products that are made with a chemical extraction process, the method used by My CBD Potion is cleaner and more efficient, with less residual byproduct left behind.

My CBD Potion products are manufactured in a GMP (Good Manufacturing Practices) certified facility in central Florida. The finished product utilizes flavors and fragrances made from natural sources, for the optimal CBD potion.

"The products produced by My CBD Potion are carefully crafted to provide the highest-quality hemp-derived CBD the world has ever seen," said Gary DeAngelo, co-founder.

What makes My CBD Potion better than other CBD products?

My CBD Potion oils are always Buy One bottle, Get One FREE! They also offer skincare products, CBD oil for pets and pain relief products. Shop the full line of My CBD Potion products at https://www.mycbdpotion.com/.

 

SOURCE My CBD Potion


These press releases may also interest you

at 01:05
Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth
Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2024. Record net sales of 1.071 billion USD in the first quarter of 2024, surpassing for the first time the 1...

at 01:00
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

at 00:30
Clayfin Technologies and Jana Small Finance Bank Honored with Prestigious IBSi Digital Banking Award 2024
Clayfin Technologies, a leading provider of innovative Digital Customer Experience solutions for Banks and Financial institutions, and Jana Small Finance Bank, one of India's leading small finance bank in India, proudly announced their partnership's...

at 00:00
Business growth stunted by manual tasks, Tipalti study finds
Tipalti, the leading global finance automation company, today reveals the majority of finance leaders (82%) admit that excessive manual finance processes are hindering their organization's growth plans for the year ahead?with two-thirds (66%) saying...

at 00:00
NyquistAI - Advancing Beyond Data to AI Transformation for Life Sciences
NyquistAI, formerly known as Nyquist Data, is making a strategic pivot that aligns with our evolution as a company and our commitment to the life sciences sector to help companies in life sciences embark on AI transformation within their...

23 avr 2024
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Innoviz Technologies Ltd. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Innoviz Technologies Ltd. ("Innoviz" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934...

More news about Business...


News published on and distributed by: